Benjamin L. Palleiko
2018
In 2018, Benjamin L. Palleiko earned a total compensation of $820.8K as Chief Business Officer and Chief Financial Officer at Carbylan Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $307,000 |
|---|---|
| Option Awards | $163,031 |
| Salary | $340,000 |
| Other | $10,800 |
| Total | $820,831 |
Palleiko received $340K in salary, accounting for 41% of the total pay in 2018.
Palleiko also received $307K in bonus, $163K in option awards and $10.8K in other compensation.
Rankings
In 2018, Benjamin L. Palleiko's compensation ranked 10,080th out of 14,244 executives tracked by ExecPay. In other words, Palleiko earned more than 29.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,080 out of 14,244 | 29th |
Division Manufacturing | 4,071 out of 5,765 | 29th |
Major group Chemicals And Allied Products | 1,531 out of 2,128 | 28th |
Industry group Drugs | 1,294 out of 1,817 | 29th |
Industry Pharmaceutical Preparations | 993 out of 1,391 | 29th |
Source: SEC filing on August 23, 2019.
Palleiko's colleagues
We found two more compensation records of executives who worked with Benjamin L. Palleiko at Carbylan Therapeutics in 2018.